Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rama Satyanarayana Raju (Udhagamandalam, India), Rama Satyanarayana Raju, M.N. Sathish Kumar, Elango Kannan, Nilesh S. Ambhore, Shashank Mulukutla, K. Gowthamarajan. Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system. Eur Respir J 2015; 46: Suppl. 59, 5011

Member's Comments

No comment yet.

Related content which might interest you: Enhanced anti-inflammatory gene expression in humans following inhaled budesonide Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Effect of antistatic AeroChamber Plus® Flow-Vu® spacer on the systemic bioavailability of CHF5993 a novel triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Fast, efficient and realistic in vitro delivery of inhaled drugs to pulmonary cells: Application to the proteasome inhibitor bortezomib Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 The electrophilic 17-oxo-DHA enhances the anti-inflammatory efficacy of fluticasone propionate in COPD patients Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Efficacy and safety of VR475 (budesonide suspension delivered by the VR475 Inhalation System) as add-on treatment in patients with severe asthma (CLEARCUT Study) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017 Nanostructured lipid carriers as drug delivery systems for fluticasone propionate: Effects in cigarette smoke stimulated bronchial epithelial cells Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 The electrophilic 17-oxo-docosahexaenoic acid (17-oxo-DHA) enhances the anti-inflammatory potency of fluticasone propionate Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Stimulation with polyinosinic-polycytidylic acid (poly(I:C)) encapsulated within novel pH-sensitive switchable liposomes leads to a faster and more potent interferon response Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 In vitro validation of the use of a spacer with an extrafine beclomethasone/formoterol formulation Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Redefining the asthma treatment paradigm using a locally administered dual PI3Kgd inhibitor Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Antiinflammatory properties of PAH drugs Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 The novel elastase inhibitor BAY 85-8501: Bioavailability and Food effect study to evaluate pharmacokinetics of tablet formulations Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 In vitro pharmacological characterization of a novel p38α (MAPK14) inhibitor designed for inhaled delivery Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016